| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $693.0K | $43.2M | $59.7M |
| YoY Revenue Growth % | -98.4% | -27.6% | — |
| Gross Profit | $589.0K | $561.0K | — |
| Gross Margin % | 85.0% | 1.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$11.6M | -$13.0M | -$28.6M |
| Operating Margin % | -80.0% | -30.0% | -48.0% |
| Net Income (GAAP) | -$22.5M | -$28.7M | -$26.2M |
| EBITDA (Normalized) | -$11.2M | -$10.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$20.6M | -$19.8M | -$18.8M |
| Capital Expenditures (CapEx) | $448.0K | $3.8M | — |
| Free Cash Flow (FCF) | -$21.1M | -$23.6M | -$18.8M |
| FCF Margin % | -80.0% | -54.5% | -31.5% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $11.2M | $5.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$21.1M | -$10.6M | — |